Webcast of a high-level training event for senior members of the medical antibiotic stewardship community to inform them on preliminary DRIVE-AB Work Package 1A (Responsible use of antibiotics) results, receive stakeholder feedback, and discuss ways to achieve consistency in the implementation of quantitative metrics and quality indicators of responsible antibiotic across Europe and further abroad.
Welcome address – Judy Hackett, DRIVE-AB and AstraZeneca
DRIVE AB’s vision and solutions – Stephan Harbarth, DRIVE-AB and University of Geneva
Governance and finance recommendations from DRIVE-AB – Christine Ärdal, DRIVE-AB and Norwegian Institute of Public Health
How do we capture the societal value of antibiotics? – Ramanan Laxminarayan, DRIVE-AB, University of Strathclyde and Center for Disease Dynamics, Economics and Policy
Surveillance and predicting future need for antibiotics – Yehuda Carmeli, DRIVE-AB and Tel Aviv University
The need to increase R&D push incentives and effective pipeline co-ordination – Ursula Theuretzbacher, DRIVE-AB and Center for Anti-Infective Agents
A review of proposed models, their implementation and how they deliver on each of the DRIVE AB pillars – David Findlay, DRIVE-AB and GlaxoSmithKline
Closing remarks – Stephan Harbarth, DRIVE-AB and University of Geneva
Back to DRIVE-AB Outputs
